Kiniksa Pharmaceuticals International, plc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Kiniksa Pharmaceuticals International, plc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • Kiniksa Pharmaceuticals International, plc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $46.3M, a 136% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $46.3M +$26.7M +136% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $19.6M -$108M -84.7% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $128M +$119M +1275% Dec 31, 2021 10-K 2024-02-28
Q4 2020 $9.31M +$8.98M +2720% Dec 31, 2020 10-K 2023-03-02
Q1 2020 $5.41M Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $330K +$281K +573% Dec 31, 2019 10-K 2023-03-02
Q4 2018 $49K +$22K +81.5% Dec 31, 2018 10-K 2022-02-24
Q4 2017 $27K +$17K Dec 31, 2017 10-K 2021-02-25
Q4 2016 $10K* Dec 31, 2016 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.